For following the competition: what moved in each program, several studies read as one move.
- elacestrant
- KAT6 Inhibitor MEN2312
- RPX7009
- + 4 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Menarini Group to watchlistEvery Monday by email · turn it off any timePro · free during the beta